Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions. Issue 4 (22nd January 2020)

• Record Type: Journal Article
• Authors: Tsunekuni, Ryota; Tanikawa, Taichiro; Nakaya, Takaaki; Saito, Takehiko
• Is Part Of: Vaccine. Volume 38:Issue 4(2020)
• Page Start: 822
• Page End: 829
• Publication Date: 2020-01-22
• Subjects: Avian avulavirus (AAvV) -- Highly pathogenic avian influenza (HPAI) -- Vaccine vector -- Emergency vaccination -- Untranslated region (UTR); AI avian influenza -- AIV avian influenza virus -- AAvV-10 avian avulavirus serotype 10 -- CEF chicken embryo fibroblast -- dpc day post-challenge -- dpv day post-vaccination -- EID50 median embryo infectious dose -- ELISA enzyme-linked immunosorbent assay -- GE gene end -- GS gene start -- HA hemagglutinin -- HI hemagglutination inhibition -- HPAI highly pathogenic avian influenza -- HPAIV highly pathogenic avian influenza virus -- hpi hour post-inoculation -- MEM minimum essential medium -- MOI multiplicity of infection -- NDV Newcastle disease virus -- ORF open reading frame -- RNA-seq RNA sequencing -- rNDV recombinant NDV -- TCID50 50% infectious doses in cells -- UTR untranslated region; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2019.10.098
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Avian avulavirus serotype 10 (AAvV-10) is a vaccine vector used in chicken. rAAvV-10/HA was modified to enhance HA gene expression and vaccine efficacy. Untranslated regions (UTRs) flanking the HA gene enhanced HA gene expression. UTRs flanking the HA gene greatly enhanced vaccine efficacy in chicken. Abstract: Background: We have previously developed a recombinant avian avulavirus serotype 10 (rAAvV-10/HA) expressing the hemagglutinin (HA) gene of a highly pathogenic avian influenza virus (HPAIV) as an emergency vaccine for poultry. rAAvV-10/HA can overcome the activity of the anti-AAvV-1 (Newcastle disease virus) antibody acquired by commercial chickens upon routine vaccination. Most chickens do not have the anti-AAvV-10 antibody, which could interfere with the vaccine efficacy. However, the vaccine efficacy of rAAvV-10/HA is not satisfactory in chickens even though it affords protection against an HPAIV challenge. In the present study, we improved the rAAvV-10/HA vaccine by enhancing the expression of the exogenous HA protein. Methods: The 5′ and 3′ untranslated regions (UTR) of each AAvV-10 gene were flanked with the exogenous HA gene cassette to modify rAAvV-10/HA, yielding different rAAv10-UTRs. As a control, rAAv10-nonUTR that did not contain any UTRs was generated. The effects of UTRs on mRNA transcription, HA protein expression, and vaccine efficacy were then examined using embryonated chicken eggs and white leghorn chickens. Results: The proportion of the HA gene mRNA among the vector-derived mRNAs (1.55–1.84-fold increase vs. the control) and HA protein levels (148–1151-fold increase vs. the control) in cells infected with rAAv10-UTRs were higher than in those infected with rAAv10-nonUTR. In vivo, vaccination of chickens with rAAv10-UTRs resulted in 100% protection against an HPAIV challenge. No chickens vaccinated with rAAv10-NP-UTR, rAAv10-F-UTR, or rAAv10-HN-UTR shed the virus in the throat and cloaca swabs. By contrast, rAAv10-nonUTR vaccination offered 70% protection, with 50% of chickens shedding the virus in the cloaca or throat swabs after the challenge. We conclude that the AAvV-10 UTRs can enhance the expression of the exogenous HA gene, resulting in improved efficacy of the rAAvV-10/HA vector vaccine. This improvement aids in the protection of flocks worldwide from the highly pathogenic avian influenza.